ArticleBritish journal of pharmacology2018

3'-Sialyllactose as an inhibitor of p65 phosphorylation ameliorates the progression of experimental rheumatoid arthritis.

Li-Jung Kang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.